NIA Funding Opportunities

Read about the latest opportunities (published in March 2024) by clicking on the links below.

• PAR-24-121: Institutional Training Programs to Advance Translational Research on Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
• PAR-24-160: New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
• PAR-24-161: New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
• RFA-AG-25-017: Exploring Proteogenomic Approaches to Unravel the Mechanisms of Mis-Folded Protein Accumulation in Tauopathies (R01 Clinical Trial Not Allowed
• RFA-AG-25-009: Research Training in Aging for Medical Students (T35)
• RFA-AG-25-012: Nathan Shock Centers of Excellence in Basic Biology of Aging (P30 Clinical Trial Not Allowed)
• RFA-AG-25-013: Nathan Shock Centers Coordinating Center (U24 Clinical Trial Not Allowed)

Notices

• NOT-AG-24-004: Notice of Special Interest (NOSI): U.S. Health in the International Perspective
• NOT-AG-24-007: Notice of Pre-Application Webinar for RFA-AG-25-005: Open Measurement Coordinating Network for Non-Pharmacological Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) Primary Prevention Trials (U24 Clinical Trial Not Allowed)
  • Explore FAQs about RFA-AG-25-005
• NOT-AG-24-003: Notice of Participation of the National Institute on Aging in NOT-OD-24-044
• NOT-AG-24-008: Notice of Correction to Key Dates Listed in PAR-24-091 and PAR-24-092 _ Multidisciplinary Studies of HIV/AIDS and Aging (R01 & R21 Clinical Trial Optional)
• NOT-AG-24-006: Notice of Change to Expiration Date for PAR-21-220, NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed)
• NOT-AG-23-085: Notice of Change to Budget Information Listed in PAR-21-357, “Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)”
• NOT-AG-24-014: Notice of Change to Letter of Intent Due Date(s) Information Listed in RFA-AG-24-001, “Alzheimer’s Disease Research Centers (P30 Clinical Trial Not Allowed)”

You may also be interested in:

• Learning about the Nathan Shock Centers of Excellence
• Reading about NIH CARD’s Data Science Master’s Degree Fellowship